
Medical chatbot firm OpenEvidence raises $210m
OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.
Newsletters and Deep Dive digital magazine
OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.
Novartis' breast cancer therapy Kisqali has been cleared for NHS use in early breast cancer, an indication driving blockbuster sales of the drug.
EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.
An NHS trust in England is starting a pilot study of a digital health platform that promises to improve the care of people with kidney disease.
For people living with serious mental illnesses, engaging in sports (or any kind of exercise) can contribute to both physical and mental health.
Editor's Picks
Newsletters and Deep Dive
digital magazine